RDHL
RedHill Biopharma Ltd.
There isn't enough reported data to score RDHL yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
RDHL Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Unavailable |
RDHL's profitability is currently healthy. There isn't enough data to rate its revenue, cash flow and balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
RDHL PE Valuation
RDHL has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
RDHL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| -- | |
| Limited | |
| High |
Analysts expect RDHL's losses to shrink, with revenue growing.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
RDHL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2023 | $0.25 | +$120.25 |
| Q2 2023 | -$59.00 | +$99.35 |
| Q4 2022 | -$120.00 | +$98.35 |
| Q2 2020 | -$300.00 | -$153.15 |
| Q4 2019 | -$280.00 | -$103.15 |
| Q4 2018 | -$176.85 | +$83.15 |
| Q4 2017 | -$260.00 | +$890.00 |
RDHL has returned to profit: it earned $0.25 per share over the past year, after losing money the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over RDHL in the latest year-over-year earnings comparison.
RDHL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2025 | $4.1M | +59% |
| Q4 2024 | $5.5M | +382% |
| Q2 2024 | $2.6M | -52% |
| Q4 2023 | $1.1M | -96% |
| Q2 2023 | $5.4M | -83% |
| Q4 2022 | $30.4M | -31% |
| Q2 2022 | $31.5M | -25% |
| Q4 2021 | $43.7M | +3% |
RDHL's revenue has slid since its 2021 peak: $4M last quarter, down 24% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2025 | -107% | -565 points |
| Q4 2024 | -113% | -57 points |
| Q2 2024 | -328% | -247 points |
| Q4 2023 | -1061% | -974 points |
| Q2 2023 | 457% | +560 points |
| Q4 2022 | -56% | +24 points |
| Q2 2022 | -82% | +52 points |
| Q4 2021 | -87% | +635 points |
RDHL's operating margin was −107% last quarter, down 565 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over RDHL in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
RDHL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2025 | -$5M | +$1.2M |
| Q4 2024 | -$3.2M | +$14.9M |
| Q2 2024 | -$6.2M | +$11.6M |
| Q4 2023 | -$18M | -$9.6M |
| Q2 2023 | -$17.8M | +$3.1M |
| Q4 2022 | -$8.5M | +$25.4M |
| Q2 2022 | -$20.9M | +$10.3M |
| Q4 2021 | -$33.9M | -$11.8M |
RDHL has burned cash in almost every quarter: −$32M over the past year, against −$81M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
RDHL Net Leverage
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
RDHL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.9 | Neutral |
| Stochastic | 2.1 | Oversold |
RDHL's weekly RSI is 31 (neutral) and its Stochastic is 2 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
RDHL PE vs Healthcare Sector
RDHL has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
RDHL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.45 | 16% below |
| 20 week MA | $0.58 | 34% below |
| 50 week MA | $0.84 | 55% below |
| 100 week MA | $1.75 | 78% below |
| 200 week MA | $20.6 | 98% below |
RDHL is in a downtrend: it's below all five of its weekly moving averages, and 98% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over RDHL on trend strength, trading above more of its moving averages.
RDHL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6,050.0 | $9,320.0 | +54% |
| 2021 | $9,320.0 | $2,640.0 | -72% |
| 2022 | $2,640.0 | $158.5 | -94% |
| 2023 | $158.5 | $36.5 | -77% |
| 2024 | $36.5 | $6.91 | -81% |
| 2025 | $6.91 | $1.14 | -84% |
| 2026 YTD | $1.14 | $0.38 | -67% |
RDHL has finished five years in a row lower, and it's down 67% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over RDHL on returns for 2026, with the stronger performance.